Case Report
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 16, 2015; 3(10): 900-903
Published online Oct 16, 2015. doi: 10.12998/wjcc.v3.i10.900
Acute hepatitis after amiodarone infusion
Paulo Fonseca, Adelaide Dias, Helena Gonçalves, Aníbal Albuquerque, Vasco Gama
Paulo Fonseca, Adelaide Dias, Helena Gonçalves, Aníbal Albuquerque, Vasco Gama, Cardiology Department, Gaia Hospital Center, 4434-502 Vila Nova de Gaia, Portugal
Author contributions: Fonseca P, Dias A and Gonçalves H wrote the case report; Albuquerque A and Gama V revised the manuscript.
Institutional review board statement: IRB approval was not required for this case report.
Informed consent statement: The patient gave his informed consent to the publication of this clinical case.
Conflict-of-interest statement: The authors declare that there is no conflict of interests regarding the publication of this article.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Paulo Fonseca, MD, Cardiology Department, Gaia Hospital Center, Rua Conceição Fernandes, 4434-502 Vila Nova de Gaia, Portugal. paulobarbosafonseca@hotmail.com
Telephone: +351-22-7865100 Fax: +351-22-7830209
Received: January 20, 2015
Peer-review started: January 21, 2015
First decision: March 6, 2015
Revised: April 18, 2015
Accepted: August 10, 2015
Article in press: August 11, 2015
Published online: October 16, 2015
Processing time: 269 Days and 9.2 Hours
Core Tip

Core tip: We report a rare case of acute hepatitis induced by intravenous amiodarone in a patient with non-sustained ventricular tachycardia. The physiopathology of this adverse effect is still unclear. Close monitoring of hepatic function during amiodarone infusion is essential to avoid any potential hepatotoxicity.